ROCEPHIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rocephin, and when can generic versions of Rocephin launch?
Rocephin is a drug marketed by Hoffmann La Roche and Roche and is included in five NDAs.
The generic ingredient in ROCEPHIN is ceftriaxone sodium; lidocaine. There are two drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ROCEPHIN?
- What are the global sales for ROCEPHIN?
- What is Average Wholesale Price for ROCEPHIN?
Summary for ROCEPHIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 20 |
| Patent Applications: | 4,871 |
| DailyMed Link: | ROCEPHIN at DailyMed |
Recent Clinical Trials for ROCEPHIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ng Teng Fong General Hospital | Phase 3 |
| John Hunter Hospital | Phase 3 |
| Singapore General Hospital | Phase 3 |

